PODD vs TRDA · P/E 34, rev $2.07B vs P/E 12, rev $210.8M
Insulet Corporation (PODD) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the PODD and TRDA stock pages for the full models.
Not investment advice.